Peter-Paul Zwetsloot

7PUBLICATIONS
77CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 24, 2026
Clinical Characteristics and Outcomes of Hypertrophic Cardiomyopathy Associated With Thin Filament Variants: Insights From the SHaRe Registry.

|Sep 14, 2026
A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study.

|Aug 10, 2026
The Dutch cardiomyopathy registry (DCR); rationale and registry design.

|Apr 17, 2026
The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

|Nov 09, 2024
Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study.

Stephan A C Schoonvelde, Isabell Wiethoff, Peter-Paul Zwetsloot

|Jan 20, 2022
Combined meta-analysis of preclinical cell therapy studies shows overlapping effect modifiers for multiple diseases.

Peter-Paul Zwetsloot, Ana Antonic-Baker, Hendrik Gremmels

Pageof 2

Frequent Collaborators

3 joint publications

Michelle Michels

2 joint publications

Francesca Girolami

2 joint publications

Kimberly Y Lin

2 joint publications

Joseph W Rossano